{
    "info": {
        "nct_id": "NCT04553133",
        "official_title": "PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPY",
        "inclusion_criteria": "* Participants with HR-positive HER2-negative advanced or metastatic breast cancer (received at least two prior lines in the advanced or metastatic setting including one prior line of combined CDK4/6 inhibitor and endocrine therapy and no more than two prior lines of cytotoxic chemotherapy)\n* Participants with locally recurrent/advanced or metastatic TNBC who have received up to 2 prior lines of chemotherapy in the advanced or metastatic setting\n* Participants with advanced platinum resistant epithelial ovarian cancer (EOC)/fallopian tube cancer/primary peritoneal cancer (PPC) (histologically or cytologically proven) who have received at least 1 systemic anti-cancer therapy containing a platinum analog\n* Participants with cytological diagnosis of advanced/metastatic SCLC\n* Participants with or cytological diagnosis of advanced/metastatic NSCLC\n* Participants with HR-positive HER2-negative advanced or metastatic breast cancer (second line plus setting) (histologically or cytologically proven).\n* Participants entering the study in the expansion cohort have at least one measurable lesion as defined by RECIST version 1.1 that has not been previously irradiated\n* Performance Status 0 or 1\n* Adequate bone marrow, hematological, kidney and liver function\n* Resolved acute effects of any prior therapy to baseline severity\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Participants with known symptomatic brain metastases requiring steroids\n* Participants with any other active malignancy within 3 years prior to enrollment\n* Major surgery within 3 weeks prior to study entry\n* Radiation therapy within 3 weeks prior to study entry.\n* Systemic anti cancer therapy within 4 weeks prior to study\n* Prior irradiation to >25% of the bone marrow\n* Participants with active, uncontrolled bacterial, fungal, or viral infection, including HBV, HCV, and known HIV or AIDS related illness\n* Active COVID-19/SARS-CoV2 infection\n* Baseline 12 lead ECG that demonstrates clinically relevant abnormalities that may affect participant safety or interpretation of study results\n* Any of the following in the previous 6 months: myocardial infarction, long QT syndrome, Torsade de Pointes, arrhythmias, serious conduction system abnormalities, unstable angina, coronary/peripheral artery bypass graft, symptomatic CHF, New York Heart Association class III or IV, cerebrovascular accident, transient ischemic attack, symptomatic pulmonary embolism, and/or other clinical significant episode of thrombo embolic disease.\n* Anticoagulation with vitamin K antagonists or factor Xa inhibitors is not allowed.\n* Hypertension that cannot be controlled by medications\n* Participation in other studies involving investigational drug(s) within 2 weeks prior to study entry.\n* Known or suspected hypersensitivity to active ingredient/excipients in PF 07104091.\n* Active inflammatory gastrointestinal disease, chronic diarrhea, known diverticular disease or previous gastric resection or lap band surgery.\n* Participants with advanced/metastatic, symptomatic, visceral spread, that are at risk of life threatening complications in the short\n* Participants with an indwelling catheter that has an external component such as those used for drainage of effusion(s) or central venous catheter that is externally\n* Previous high dose chemotherapy requiring stem cell rescue\n* Known abnormalities in coagulation such as bleeding diathesis, or treatment with anticoagulants precluding intramuscular injections of goserelin (if applicable).\n* Current use or anticipated need for food or drugs that are known strong CYP3A4/5 or UGT1A9 inhibitors or inducers\n* Current use or anticipated need for drugs that are known sensitive UGT1A1 substrates with narrow therapeutic\n* Serum pregnancy test positive at screening\n* Other medical or psychiatric condition",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Participants with locally recurrent/advanced or metastatic TNBC who have received up to 2 prior lines of chemotherapy in the advanced or metastatic setting",
            "criterions": [
                {
                    "exact_snippets": "locally recurrent/advanced or metastatic TNBC",
                    "criterion": "TNBC disease status",
                    "requirements": [
                        {
                            "requirement_type": "disease subtype",
                            "expected_value": "triple-negative breast cancer (TNBC)"
                        },
                        {
                            "requirement_type": "disease stage",
                            "expected_value": [
                                "locally recurrent",
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "up to 2 prior lines of chemotherapy in the advanced or metastatic setting",
                    "criterion": "prior lines of chemotherapy in advanced/metastatic setting",
                    "requirements": [
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "lines"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with HR-positive HER2-negative advanced or metastatic breast cancer (second line plus setting) (histologically or cytologically proven).",
            "criterions": [
                {
                    "exact_snippets": "HR-positive HER2-negative advanced or metastatic breast cancer",
                    "criterion": "breast cancer subtype",
                    "requirements": [
                        {
                            "requirement_type": "hormone receptor status",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "HER2 status",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "disease stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "second line plus setting",
                    "criterion": "treatment line",
                    "requirements": [
                        {
                            "requirement_type": "minimum prior lines of therapy",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "lines"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically or cytologically proven",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically proven",
                                "cytologically proven"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Resolved acute effects of any prior therapy to baseline severity",
            "criterions": [
                {
                    "exact_snippets": "Resolved acute effects of any prior therapy to baseline severity",
                    "criterion": "acute effects of prior therapy",
                    "requirements": [
                        {
                            "requirement_type": "resolution",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "baseline"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate bone marrow, hematological, kidney and liver function",
            "criterions": [
                {
                    "exact_snippets": "Adequate bone marrow ... function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hematological ... function",
                    "criterion": "hematological function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... kidney ... function",
                    "criterion": "kidney function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... liver function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Performance Status 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Performance Status 0 or 1",
                    "criterion": "performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with advanced platinum resistant epithelial ovarian cancer (EOC)/fallopian tube cancer/primary peritoneal cancer (PPC) (histologically or cytologically proven) who have received at least 1 systemic anti-cancer therapy containing a platinum analog",
            "criterions": [
                {
                    "exact_snippets": "advanced platinum resistant epithelial ovarian cancer (EOC)/fallopian tube cancer/primary peritoneal cancer (PPC)",
                    "criterion": "cancer type and status",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": [
                                "epithelial ovarian cancer",
                                "fallopian tube cancer",
                                "primary peritoneal cancer"
                            ]
                        },
                        {
                            "requirement_type": "disease status",
                            "expected_value": "advanced"
                        },
                        {
                            "requirement_type": "platinum resistance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically or cytologically proven",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically proven",
                                "cytologically proven"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "have received at least 1 systemic anti-cancer therapy containing a platinum analog",
                    "criterion": "prior systemic anti-cancer therapy containing a platinum analog",
                    "requirements": [
                        {
                            "requirement_type": "number of therapies",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "systemic anti-cancer therapy containing a platinum analog"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with or cytological diagnosis of advanced/metastatic NSCLC",
            "criterions": [
                {
                    "exact_snippets": "cytological diagnosis of advanced/metastatic NSCLC",
                    "criterion": "NSCLC diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "cytological"
                        },
                        {
                            "requirement_type": "disease_stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with cytological diagnosis of advanced/metastatic SCLC",
            "criterions": [
                {
                    "exact_snippets": "cytological diagnosis of advanced/metastatic SCLC",
                    "criterion": "small cell lung cancer (SCLC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "cytological"
                        },
                        {
                            "requirement_type": "disease_stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants entering the study in the expansion cohort have at least one measurable lesion as defined by RECIST version 1.1 that has not been previously irradiated",
            "criterions": [
                {
                    "exact_snippets": "at least one measurable lesion as defined by RECIST version 1.1",
                    "criterion": "measurable lesion (RECIST v1.1)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "definition",
                            "expected_value": "RECIST version 1.1"
                        }
                    ]
                },
                {
                    "exact_snippets": "that has not been previously irradiated",
                    "criterion": "measurable lesion prior irradiation status",
                    "requirements": [
                        {
                            "requirement_type": "previous irradiation",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with HR-positive HER2-negative advanced or metastatic breast cancer (received at least two prior lines in the advanced or metastatic setting including one prior line of combined CDK4/6 inhibitor and endocrine therapy and no more than two prior lines of cytotoxic chemotherapy)",
            "criterions": [
                {
                    "exact_snippets": "HR-positive HER2-negative advanced or metastatic breast cancer",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "hormone receptor status",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "HER2 status",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "disease stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "received at least two prior lines in the advanced or metastatic setting",
                    "criterion": "prior lines of therapy in advanced or metastatic setting",
                    "requirements": [
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "lines"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "including one prior line of combined CDK4/6 inhibitor and endocrine therapy",
                    "criterion": "prior combined CDK4/6 inhibitor and endocrine therapy",
                    "requirements": [
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "line"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "no more than two prior lines of cytotoxic chemotherapy",
                    "criterion": "prior lines of cytotoxic chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "lines"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Radiation therapy within 3 weeks prior to study entry.",
            "criterions": [
                {
                    "exact_snippets": "Radiation therapy within 3 weeks prior to study entry.",
                    "criterion": "radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "timing since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active inflammatory gastrointestinal disease, chronic diarrhea, known diverticular disease or previous gastric resection or lap band surgery.",
            "criterions": [
                {
                    "exact_snippets": "Active inflammatory gastrointestinal disease",
                    "criterion": "inflammatory gastrointestinal disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic diarrhea",
                    "criterion": "chronic diarrhea",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known diverticular disease",
                    "criterion": "diverticular disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "previous gastric resection",
                    "criterion": "gastric resection",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lap band surgery",
                    "criterion": "lap band surgery",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with an indwelling catheter that has an external component such as those used for drainage of effusion(s) or central venous catheter that is externally",
            "criterions": [
                {
                    "exact_snippets": "Participants with an indwelling catheter that has an external component such as those used for drainage of effusion(s) or central venous catheter that is externally",
                    "criterion": "indwelling catheter with external component",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "drainage of effusion(s)",
                    "criterion": "catheter used for drainage of effusion(s)",
                    "requirements": [
                        {
                            "requirement_type": "usage",
                            "expected_value": "drainage of effusion(s)"
                        }
                    ]
                },
                {
                    "exact_snippets": "central venous catheter that is externally",
                    "criterion": "externally placed central venous catheter",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Previous high dose chemotherapy requiring stem cell rescue",
            "criterions": [
                {
                    "exact_snippets": "Previous high dose chemotherapy requiring stem cell rescue",
                    "criterion": "previous high dose chemotherapy requiring stem cell rescue",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Baseline 12 lead ECG that demonstrates clinically relevant abnormalities that may affect participant safety or interpretation of study results",
            "criterions": [
                {
                    "exact_snippets": "Baseline 12 lead ECG that demonstrates clinically relevant abnormalities that may affect participant safety or interpretation of study results",
                    "criterion": "12 lead ECG",
                    "requirements": [
                        {
                            "requirement_type": "abnormalities",
                            "expected_value": "clinically relevant abnormalities that may affect participant safety or interpretation of study results"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Anticoagulation with vitamin K antagonists or factor Xa inhibitors is not allowed.",
            "criterions": [
                {
                    "exact_snippets": "Anticoagulation with vitamin K antagonists or factor Xa inhibitors is not allowed.",
                    "criterion": "anticoagulation with vitamin K antagonists or factor Xa inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participation in other studies involving investigational drug(s) within 2 weeks prior to study entry.",
            "criterions": [
                {
                    "exact_snippets": "Participation in other studies involving investigational drug(s) within 2 weeks prior to study entry.",
                    "criterion": "participation in other studies involving investigational drugs",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks prior to study entry"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum pregnancy test positive at screening",
            "criterions": [
                {
                    "exact_snippets": "Serum pregnancy test positive at screening",
                    "criterion": "serum pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known abnormalities in coagulation such as bleeding diathesis, or treatment with anticoagulants precluding intramuscular injections of goserelin (if applicable).",
            "criterions": [
                {
                    "exact_snippets": "Known abnormalities in coagulation",
                    "criterion": "coagulation abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bleeding diathesis",
                    "criterion": "bleeding diathesis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "treatment with anticoagulants precluding intramuscular injections of goserelin",
                    "criterion": "treatment with anticoagulants precluding intramuscular injections of goserelin",
                    "requirements": [
                        {
                            "requirement_type": "treatment",
                            "expected_value": "anticoagulants"
                        },
                        {
                            "requirement_type": "effect",
                            "expected_value": "precludes intramuscular injections of goserelin"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any of the following in the previous 6 months: myocardial infarction, long QT syndrome, Torsade de Pointes, arrhythmias, serious conduction system abnormalities, unstable angina, coronary/peripheral artery bypass graft, symptomatic CHF, New York Heart Association class III or IV, cerebrovascular accident, transient ischemic attack, symptomatic pulmonary embolism, and/or other clinical significant episode of thrombo embolic disease.",
            "criterions": [
                {
                    "exact_snippets": "myocardial infarction ... in the previous 6 months",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "long QT syndrome ... in the previous 6 months",
                    "criterion": "long QT syndrome",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Torsade de Pointes ... in the previous 6 months",
                    "criterion": "Torsade de Pointes",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "arrhythmias ... in the previous 6 months",
                    "criterion": "arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "serious conduction system abnormalities ... in the previous 6 months",
                    "criterion": "serious conduction system abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina ... in the previous 6 months",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary/peripheral artery bypass graft ... in the previous 6 months",
                    "criterion": "coronary/peripheral artery bypass graft",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic CHF ... in the previous 6 months",
                    "criterion": "symptomatic CHF",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "New York Heart Association class III or IV ... in the previous 6 months",
                    "criterion": "New York Heart Association class III or IV",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "cerebrovascular accident ... in the previous 6 months",
                    "criterion": "cerebrovascular accident",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "transient ischemic attack ... in the previous 6 months",
                    "criterion": "transient ischemic attack",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic pulmonary embolism ... in the previous 6 months",
                    "criterion": "symptomatic pulmonary embolism",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "other clinical significant episode of thrombo embolic disease ... in the previous 6 months",
                    "criterion": "other clinically significant episode of thromboembolic disease",
                    "requirements": [
                        {
                            "requirement_type": "occurrence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hypertension that cannot be controlled by medications",
            "criterions": [
                {
                    "exact_snippets": "Hypertension that cannot be controlled by medications",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "controllability by medications",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with active, uncontrolled bacterial, fungal, or viral infection, including HBV, HCV, and known HIV or AIDS related illness",
            "criterions": [
                {
                    "exact_snippets": "active, uncontrolled bacterial, fungal, or viral infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "bacterial",
                                "fungal",
                                "viral"
                            ]
                        },
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "including HBV, HCV, and known HIV or AIDS related illness",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "HBV",
                                "HCV",
                                "HIV",
                                "AIDS related illness"
                            ]
                        },
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgery within 3 weeks prior to study entry",
            "criterions": [
                {
                    "exact_snippets": "Major surgery within 3 weeks prior to study entry",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active COVID-19/SARS-CoV2 infection",
            "criterions": [
                {
                    "exact_snippets": "Active COVID-19/SARS-CoV2 infection",
                    "criterion": "COVID-19/SARS-CoV2 infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known or suspected hypersensitivity to active ingredient/excipients in PF 07104091.",
            "criterions": [
                {
                    "exact_snippets": "Known or suspected hypersensitivity to active ingredient/excipients in PF 07104091.",
                    "criterion": "hypersensitivity to active ingredient/excipients in PF 07104091",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior irradiation to >25% of the bone marrow",
            "criterions": [
                {
                    "exact_snippets": "Prior irradiation to >25% of the bone marrow",
                    "criterion": "prior irradiation to bone marrow",
                    "requirements": [
                        {
                            "requirement_type": "extent",
                            "expected_value": {
                                "operator": ">",
                                "value": 25,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current use or anticipated need for food or drugs that are known strong CYP3A4/5 or UGT1A9 inhibitors or inducers",
            "criterions": [
                {
                    "exact_snippets": "Current use ... food or drugs that are known strong CYP3A4/5 or UGT1A9 inhibitors or inducers",
                    "criterion": "use of strong CYP3A4/5 or UGT1A9 inhibitors or inducers",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "anticipated need for food or drugs that are known strong CYP3A4/5 or UGT1A9 inhibitors or inducers",
                    "criterion": "anticipated need for strong CYP3A4/5 or UGT1A9 inhibitors or inducers",
                    "requirements": [
                        {
                            "requirement_type": "anticipated need",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with advanced/metastatic, symptomatic, visceral spread, that are at risk of life threatening complications in the short",
            "criterions": [
                {
                    "exact_snippets": "advanced/metastatic",
                    "criterion": "disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic",
                    "criterion": "symptom status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "visceral spread",
                    "criterion": "visceral spread",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at risk of life threatening complications in the short",
                    "criterion": "risk of life threatening complications (short term)",
                    "requirements": [
                        {
                            "requirement_type": "risk",
                            "expected_value": "at risk in the short term"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with any other active malignancy within 3 years prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "any other active malignancy within 3 years prior to enrollment",
                    "criterion": "other active malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Other medical or psychiatric condition",
            "criterions": [
                {
                    "exact_snippets": "Other medical or psychiatric condition",
                    "criterion": "medical or psychiatric condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current use or anticipated need for drugs that are known sensitive UGT1A1 substrates with narrow therapeutic",
            "criterions": [
                {
                    "exact_snippets": "Current use ... drugs that are known sensitive UGT1A1 substrates with narrow therapeutic",
                    "criterion": "use of drugs that are known sensitive UGT1A1 substrates with narrow therapeutic index",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "anticipated need for drugs that are known sensitive UGT1A1 substrates with narrow therapeutic",
                    "criterion": "anticipated need for drugs that are known sensitive UGT1A1 substrates with narrow therapeutic index",
                    "requirements": [
                        {
                            "requirement_type": "anticipated need",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systemic anti cancer therapy within 4 weeks prior to study",
            "criterions": [
                {
                    "exact_snippets": "Systemic anti cancer therapy within 4 weeks prior to study",
                    "criterion": "systemic anti-cancer therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since last therapy",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with known symptomatic brain metastases requiring steroids",
            "criterions": [
                {
                    "exact_snippets": "known symptomatic brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "known",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring steroids",
                    "criterion": "steroid requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}